CoChat

Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis

Open access
Gibbons, Michael A., MacKinnon, Alison C., Ramachandran, Prakash, Dhaliwal, Kevin, Duffin, Rodger, Phythian-Adams, Alexander T., van Rooijen, Nico, Haslett, Christopher, Howie, Sarah E., Simpson, A. John, Hirani, Nikhil, Gauldie, Jack, Iredale, John P., Sethi, Tariq, Forbes, Stuart J. · 2011 · American Journal of Respiratory and Critical Care Medicine

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Rationale: Idiopathic pulmonary fibrosis (IPF) is a devastating disease. Antiinflammatory therapies, including corticosteroids, are of no benefit. The role of monocytes and macrophages is therefore controversial. Objectives: To define the role of monocytes and macrophages during lung fibrogenesis and resolution, and explore the phenotype of the cells involved. Methods: We used multiple in vivo depletional strategies, backed up by adoptive transfer techniques. Further studies were performed on samples from patients with IPF. Measurements and Main Results: Depletion of lung macrophages during fibrogenesis reduced pulmonary fibrosis as measured by lung collagen (P = 0.0079); fibrosis score (P = 0.0051); and quantitative polymerase chain reaction for surrogate markers of fibrosis Col1 (P = 0.0083) and α-smooth muscle actin (P = 0.0349). There was an associated reduction in markers of the profibrotic alternative macrophage activation phenotype, Ym1 (P = 0.0179), and Arginase1. The alternative macrophage marker CD163 was expressed on lung macrophages from patients with IPF. Depletion of Ly6Chi circulating monocytes reduced pulmonary fibrosis (P = 0.0052) and the number of Ym1-positive alternatively activated lung macrophages (P = 0.0310). Their adoptive transfer during fibrogenesis exacerbated fibrosis (P = 0.0304); however, adoptively transferred CD45.1 Ly6Chi cells were not found in the lungs of recipient CD45.2 mice. Conclusions: We demonstrate the importance of circulating monocytes and lung macrophages during pulmonary fibrosis, and emphasize the importance of the alternatively activated macrophage phenotype. We show that Ly6Chi monocytes facilitate the progression of pulmonary fibrosis, but are not obviously engrafted into lungs thereafter. Finally, we provide empirical data to suggest that macrophages may have a resolution-promoting role during the reversible phase of bleomycin-induced pulmonary fibrosis.

Overview

Integrity signals

Registry

Crossref · 10.1164/rccm.201010-1719oc

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Research works printed but not linked: 2

  1. Gibbons, 2009, A critical role for alternatively activated monocytes and macrophages in the pathogenesis of pulmonary fibrosis [abstract], Thorax, 64, A37
  2. Gibbons, 2010, Ly6Chi circulating monocytes direct alternatively activated, pro-fibrotic, lung macrophage regulation of pulmonary fibrosis, Thorax, 65, A57

Cited by

See all 492

Metadata

Authors
Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., Hirani, N., Gauldie, J., Iredale, J. P., Sethi, T., & Forbes, S. J.
Affiliations
  • Royal Devon & Exeter NHS Foundation Trust (GB)
  • Centre for Inflammation Research (GB)
  • Institute of Immunology and Infection Research, and
  • Department of Molecular Cell Biology, Vrije University, Amsterdam, The Netherlands
  • Medical Research Council/University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Edinburgh, United Kingdom
  • McMaster University (CA)
  • King's College London (GB)
  • MRC Centre for Regenerative Medicine (GB)
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2011-09-01
Volume
184
Issue
5
Pages
569-581
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2111920665
Cited by
466
References
50
Citations by year
2026: 23 · 2025: 36 · 2024: 32 · 2023: 34 · 2022: 38 · 2021: 38 · 2020: 30 · 2019: 37 · 2018: 31 · 2017: 34 · 2016: 38 · 2015: 23 · 2014: 24 · 2013: 30 · 2012: 15
FWCI
19.59
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Keywords
idiopathic pulmonary fibrosis, pulmonary fibrosis, Ly6Chi monocytes, M2 macrophages, M2 macrophage polarization, Ym1, arginase-1, CD163, macrophage depletion, adoptive transfer, bleomycin-induced lung fibrosis, fibrosis resolution, collagen deposition
MeSH terms
Animals, Bleomycin, Disease Models, Animal, Female, Humans, Immunity, Cellular, Macrophage Activation, Monocytes, Phenotype, Pulmonary Fibrosis, Macrophages, Alveolar, Disease Progression, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis. https://app.cochat.ai/papers/10.1164/rccm.201010-1719oc
The paper
Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., Hirani, N., Gauldie, J., Iredale, J. P., Sethi, T., & Forbes, S. J. (2011). Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201010-1719oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.